The polarization of tumor-associated macrophages away from tolerogenic phenotypes and toward anti-tumor M1 macrophages suggested in the above experiments with GPX4 overexpression was also supported in selenium nanoparticle studies [164]. The gene discussed is GPX4; the disease is neoplasm.